The important role of catestatin in cardiac remodeling.

作者: Zheng Wu , Dan Zhu

DOI: 10.3109/1354750X.2014.950331

关键词:

摘要: Catestatin (CST) was first discovered as a potent non-competitive and reversible inhibitor of catecholamine secretion. Recent reports on plasma CST level in heart diseases suggested cardioprotective role for this peptide. Given that cardiac remodeling is the dominant pathologic process dysfunction, we propose participates regulation concern pathways contributes to inhibition remodeling. In minireview, potential mechanism involving will be discussed from three aspects: hypertrophy, fibrosis, apoptosis.

参考文章(75)
BERNARD SWYNGHEDAUW, Molecular Mechanisms of Myocardial Remodeling Physiological Reviews. ,vol. 79, pp. 215- 262 ,(1999) , 10.1152/PHYSREV.1999.79.1.215
Carlos J. Herrero, Eva Alés, Antonio J. Pintado, Manuela G. López, Esther Garcı́a-Palomero, Sushil K. Mahata, Daniel T. O'Connor, Antonio G. Garcı́a, Carmen Montiel, Modulatory Mechanism of the Endogenous Peptide Catestatin on Neuronal Nicotinic Acetylcholine Receptors and Exocytosis The Journal of Neuroscience. ,vol. 22, pp. 377- 388 ,(2002) , 10.1523/JNEUROSCI.22-02-00377.2002
Sugden Ph, Signalling pathways in cardiac myocyte hypertrophy. Annals of Medicine. ,vol. 33, pp. 611- 622 ,(2001)
Lin Liu, Wenhui Ding, Renxu Li, Xiaojin Ye, Jing Zhao, Jie Jiang, Lei Meng, Jie Wang, Songyun Chu, Xiaoning Han, Fen Peng, Plasma levels and diagnostic value of catestatin in patients with heart failure Peptides. ,vol. 46, pp. 20- 25 ,(2013) , 10.1016/J.PEPTIDES.2013.05.003
S. Imbrogno, F. Garofalo, M. C. Cerra, S. K. Mahata, B. Tota, The catecholamine release-inhibitory peptide catestatin (chromogranin A344-364) modulates myocardial function in fish The Journal of Experimental Biology. ,vol. 213, pp. 3636- 3643 ,(2010) , 10.1242/JEB.045567
Jiaur R. Gayen, Kuixing Zhang, Satish P. RamachandraRao, Manjula Mahata, Yuqing Chen, Hyung-Suk Kim, Robert K. Naviaux, Kumar Sharma, Sushil K. Mahata, Daniel T. O’Connor, Role of reactive oxygen species in hyperadrenergic hypertension: biochemical, physiological, and pharmacological evidence from targeted ablation of the chromogranin a (Chga) gene. Circulation-cardiovascular Genetics. ,vol. 3, pp. 414- 425 ,(2010) , 10.1161/CIRCGENETICS.109.924050
Sushil K. Mahata, Manjula Mahata, Maple M. Fung, Daniel T. O'Connor, Reprint of: Catestatin: a multifunctional peptide from chromogranin A. Regulatory Peptides. ,vol. 165, pp. 52- 62 ,(2010) , 10.1016/J.REGPEP.2010.09.007
Gabriela Kania, Przemyslaw Blyszczuk, Urs Eriksson, Mechanisms of cardiac fibrosis in inflammatory heart disease. Trends in Cardiovascular Medicine. ,vol. 19, pp. 247- 252 ,(2009) , 10.1016/J.TCM.2010.02.005
Rosa Mazza, Alfonsina Gattuso, Cinzia Mannarino, Bhawanjit K. Brar, Sandra Francesca Barbieri, Bruno Tota, Sushil K. Mahata, Catestatin (chromogranin A344-364) is a novel cardiosuppressive agent: inhibition of isoproterenol and endothelin signaling in the frog heart. American Journal of Physiology-heart and Circulatory Physiology. ,vol. 295, ,(2008) , 10.1152/AJPHEART.00172.2008
Andrea H. Gaede, Mandy S.Y. Lung, Paul M. Pilowsky, Catestatin attenuates the effects of intrathecal nicotine and isoproterenol. Brain Research. ,vol. 1305, pp. 86- 95 ,(2009) , 10.1016/J.BRAINRES.2009.09.088